COST-EFFECTIVENESS OF POST-TREATMENT FOLLOW-UP AND SECONDARY PREVENTION OF TUBERCULOSIS IN A HIGH-INCIDENCE SETTING - A MODEL-BASED ANALYSIS

被引：0
|
作者：
Marx, Florian [1 ]
Cohen, Ted [2 ]
Menzies, Nicolas [3 ]
Salomon, Joshua [4 ,5 ]
Yaesoubi, Reza [2 ]
机构：
[1] DST NRF South African Ctr Excellence Epidemiol M, Stellenbosch, South Africa
[2] Yale Sch Publ Hlth, New Haven, CT USA
[3] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA
[4] Ctr Hlth Policy, Stanford, CA USA
[5] Ctr Primary Care & Outcomes Res, Stanford, CA USA
来源：
MEDICAL DECISION MAKING | 2020年 / 40卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
5N-6
引用
收藏
页码：E360 / E361
页数：2
相关论文
共 50 条
  • [21] A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women
    Yoshimura, M.
    Moriwaki, K.
    Noto, S.
    Takiguchi, T.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (02) : 643 - 652
  • [22] A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women
    M. Yoshimura
    K. Moriwaki
    S. Noto
    T. Takiguchi
    Osteoporosis International, 2017, 28 : 643 - 652
  • [23] Non-restrictive open vial policy combined with the home visit vaccinations for improving BCG coverage in a high-incidence outreach region: A model-based cost-effectiveness analysis for Indonesia
    Machlaurin, Afifah
    Luttjeboer, Jos
    Setiawan, Didik
    van der Werf, Tjipke Sytse
    Postma, Maarten J.
    JOURNAL OF GLOBAL HEALTH, 2023, 13
  • [24] Xpert Ultra stool testing to diagnose tuberculosis in children in Ethiopia and Indonesia: a model-based cost-effectiveness analysis
    Mafirakureva, Nyashadzaishe
    Klinkenberg, Eveline
    Spruijt, Ineke
    Levy, Jens
    Shaweno, Debebe
    de Haas, Petra
    Kaswandani, Nastiti
    Bedru, Ahmed
    Triasih, Rina
    Gebremichael, Melaku
    Dodd, Peter J.
    Tiemersma, Edine W.
    BMJ OPEN, 2022, 12 (07):
  • [25] Cost-benefit and cost-effectiveness analysis of a disability prevention model for back pain management: a six year follow up study
    Loisel, P
    Lemaire, J
    Poitras, S
    Durand, MJ
    Champagne, F
    Stock, S
    Diallo, B
    Tremblay, C
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2002, 59 (12) : 807 - 815
  • [26] Cost-effectiveness of drug eluting stents in a US setting: cost-utility analysis with a decision analytic model using meta-analysis data with 3 year follow-up
    Nordmann, A. J.
    Bischof, M.
    Briel, M.
    Bucher, H. C.
    EUROPEAN HEART JOURNAL, 2007, 28 : 508 - 509
  • [27] Evaluating PET-CT in routine surveillance and follow-up after treatment for cervical cancer: a cost-effectiveness analysis
    Auguste, P.
    Barton, P.
    Meads, C.
    Davenport, C.
    Malysiak, S.
    Kowalska, M.
    Zapalska, A.
    Guest, P.
    Martin-Hirsch, P.
    Borowiack, E.
    Khan, K.
    Sundar, S.
    Roberts, T.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 (04) : 464 - 476
  • [28] Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease
    Guadagnolo, Beverly A.
    Punglia, Rinaa S.
    Kuntz, Karen M.
    Mauch, Peter M.
    Ng, Andrea K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) : 4116 - 4122
  • [29] The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis
    Andrews, Jason R.
    Lawn, Stephen D.
    Rusu, Corina
    Wood, Robin
    Noubary, Farzad
    Bender, Melissa A.
    Horsburgh, C. Robert
    Losina, Elena
    Freedberg, Kenneth A.
    Walensky, Rochelle P.
    AIDS, 2012, 26 (08) : 987 - 995
  • [30] Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis
    Bernard, Cora L.
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    Brandeau, Margaret L.
    PLOS MEDICINE, 2017, 14 (05)
12345